ActivSight Imaging for Esophageal Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
ActivSight™ combines an innovative form factor and proprietary software to deliver precise, objective, real-time visualization of blood flow and tissue perfusion intraoperatively for laparoscope-based surgery. A small adaptor that fits between any existing laparoscope and camera systems and a separate light source placed along any current commercial system will deliver objective real-time tissue perfusion and blood flow information intraoperatively.Primary Objective: To determine the feasibility of ActivSight™ in detecting and displaying tissue perfusion and blood flow in the conduit and foregut anastomoses in esophageal resection/reconstructive surgery. The investigators will compare the precision and accuracy among the naked eye inspection, ICG and LSCI in assessing the vascularity of the conduit.
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need laparoscopic esophageal surgery. They must be able to understand the study, have normal organ function, and not suffer from severe breathing issues. People with allergies to ICG or iodides, pregnant women, those on certain drugs, or with chronic kidney problems can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
ActivSight™ is used intraoperatively to visualize tissue perfusion and blood flow during esophageal surgery
Follow-up
Participants are monitored for safety and effectiveness after surgery, with a focus on adverse events and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- ActivSight
Find a Clinic Near You
Who Is Running the Clinical Trial?
Activ Surgical
Lead Sponsor
West Penn Allegheny Health System
Collaborator
University of Pittsburgh Medical Center
Collaborator